New multiple sclerosis drug could slow progression of symptoms of a form of the disease, secondary progressive MS, for which effective treatments have proved elusive. An international clinical trial found that the drug "siponimod" reduced the risk of disabilities becoming worse over time.

See the source article by following the link below:
New multiple sclerosis drug could slow progression of symptoms of a form of the disease, secondary progressive MS, for which effective treatments have proved elusive. An international clinical trial found that the drug "siponimod" reduced the risk of disabilities becoming worse over time.